Neogen's BetaStar Plus Dairy Antibiotic Test Approved by FDA/NCIMS

Neogen Corporation NEOG has received approval from the FDA and National Conference on Interstate Milk Shipments for its quick and easy BetaStar Plus assay, developed for use in the United States to detect dairy antibiotic residues, including ceftiofur, in milk. This approval allows milk producers and processors in the U.S. to use Neogen's new test to comply with FDA regulations that require the mandatory testing of raw milk tankers for dairy antibiotic residues, under Appendix N of the Pasteurized Milk Ordinance. Neogen's newly approved BetaStar Plus test detects dairy antibiotic residues in the beta-lactam group (penicillin, ampicillin, amoxicillin, cephapirin, ceftiofur and cloxacillin) at or below U.S. FDA regulatory levels. BetaStar is an extremely simple dipstick test that requires only minimal training and equipment to produce consistently accurate results. "This approval process was very thorough, and proves that our new test is fully capable of delivering the accurate results that milk producers and processors demand," said Ed Bradley, Neogen's vice president for Food Safety. "BetaStar Plus was developed specifically to meet the regulatory tolerances for beta-lactam antibiotics, including ceftiofur, for milk in the U.S. market, and is a new version of our BetaStar test that is a market leader in approximately 40 countries around the world."
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsFDAHealth CareHealth Care Supplies
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!